131 related articles for article (PubMed ID: 5952570)
1. Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum.
Miyai K; Werner SC
J Clin Endocrinol Metab; 1966 May; 26(5):504-12. PubMed ID: 5952570
[No Abstract] [Full Text] [Related]
2. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
Hardisty CA; Hanford L; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
[TBL] [Abstract][Full Text] [Related]
3. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
Chopra IJ; Solomon DH; Limberg NP
J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
[No Abstract] [Full Text] [Related]
4. LATS in Graves' disease.
McKenzie JM; Zakarija M
Recent Prog Horm Res; 1976; 33():29-57. PubMed ID: 198858
[No Abstract] [Full Text] [Related]
5. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
McKenzie JM; Zakarija M
J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
[TBL] [Abstract][Full Text] [Related]
6. Thyroid stimulating immunoglobulin in Graves' disease.
Luttrell BM; Hales IB
Aust N Z J Med; 1981 Jun; 11(3):293-8. PubMed ID: 6170289
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
[No Abstract] [Full Text] [Related]
8. Failure of immunologic reaction of long acting thyroid stimulator (LATS) to thyroid components, and the demonstration of a plasma inhibitor LATS.
Burke G
J Lab Clin Med; 1967 May; 69(5):713-27. PubMed ID: 4960804
[No Abstract] [Full Text] [Related]
9. The gamma globulin of Graves' disease: thyroid stimulation by fraction and fragment.
McKenzie JM
Trans Assoc Am Physicians; 1965; 78():174-86. PubMed ID: 4159873
[No Abstract] [Full Text] [Related]
10. Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves' disease associated with localized myxedema.
Hardisty CA; Fowles A; Munro DS
J Endocrinol Invest; 1984 Apr; 7(2):151-5. PubMed ID: 6547156
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
Gharib H; Mayberry WE
Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
[No Abstract] [Full Text] [Related]
12. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
[TBL] [Abstract][Full Text] [Related]
13. Action of globulin and lymphocytes from peripheral blood of patients with Graves' disease on isolated bovine thyroid cells.
Edmonds MW; Row VV; Volpé R
J Clin Endocrinol Metab; 1970 Nov; 31(5):480-90. PubMed ID: 5536104
[No Abstract] [Full Text] [Related]
14. The prediction of relapse after drug treatment of Graves' disease by assay of long acting thyroid stimulator-protector (LATS-P).
Hardisty CA; Hanford L; Munro DS
Clin Endocrinol (Oxf); 1981 May; 14(5):509-17. PubMed ID: 6895487
[TBL] [Abstract][Full Text] [Related]
15. [Human thyroid stimulator (HTS) in thyroid diseases].
Hu ZY
Zhonghua Nei Ke Za Zhi; 1984 Aug; 23(8):480-3, 525. PubMed ID: 6548953
[No Abstract] [Full Text] [Related]
16. [LATS production by lymphocyte culture].
Fukuchi M
Nihon Naibunpi Gakkai Zasshi; 1969 Oct; 45(7):766-77. PubMed ID: 5394607
[No Abstract] [Full Text] [Related]
17. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
[TBL] [Abstract][Full Text] [Related]
18. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
19. Familial incidence of long-acting thyroid stimulator (LATS) in Graves' disease.
Bonnyns M; Vanhaelst L
Horm Metab Res; 1972 Mar; 4(2):132. PubMed ID: 5067566
[No Abstract] [Full Text] [Related]
20. Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.
Wall JR; Good BF; Forbes IJ; Hetzel BS
Clin Exp Immunol; 1973 Aug; 14(4):555-61. PubMed ID: 4201115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
